Join us at Seqera Sessions to learn how to scale your bioinformatics workflows and accelerate the entire analysis lifecycle, from data generation to actionable insights.
About
Why attend?
- Hands-on Nextflow training: Design your first bioinformatics workflow and create workflow endpoints for automatic analysis on Seqera.
- Industry-led sessions: Hear the latest real-world genomic analysis research stories from leading innovators.
- Live demos: Launch and monitor workflows at scale on Seqera's cloud environment.
- Expert insights and networking: Stay updated on the latest advancements in bioinformatics and meet the pioneers.
Event information
Morning: Nextflow Training
Dive into the Nextflow language and build your first bioinformatics workflow in just 3 hours! You'll receive a Certificate of attendance and exclusive Seqera Swag.
Space is limited, so register early to secure your spot and level up your bioinformatics skills.
Nextflow training attendees will be asked a minimal fee to cover training costs.
Afternoon: Seqera Sessions
Free entry from 2:30 PM. Advance registration is required.
Agenda
09:00 AM
Training: Arrival & Registrations and set-up time
09:15 AM
Nextflow Fundamentals Training
1:30 PM
Lunch for Training attendees
2:30 PM
Sessions: Arrivals & Registrations
3:00 PM
Seqera Presentation and Demo: Evan Floden, CEO & Co-founder, Seqera
3:20 PM
Industry presentation with Peter Saffrey, Director of Bioinformatics and Software Engineering at biomodal
3:40 PM
Roundtable followed by Q&A with Ryvu, AstraZeneca, Biomodal and Seqera
4:05 PM
Networking over drinks/small bites
5:30 PM
End
Speakers
Miika Ahdesmäki
CIO at Ryvu, a clinical stage biopharmaceutical company developing therapeutics addressing clinical limitations of current treatments in oncology.
Manasa Surakala
Associate Director, Omics Product Lead at AstraZeneca, a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide.
Peter Saffrey
Director of Bioinformatics and Software Engineering at biomodal, a company that builds technologies and analytics as research tools for life scientists & clinical developers, by providing insight into the complexity and dynamism of cellular interactions.
Evan Floden
CEO & Co-founder at Seqera, a company empowering scientists to solve today's most complex and essential challenges; from pioneering innovative therapeutics to unveiling the secrets of our universe.